Stir Crazy in Quarantine
Well, this has been an interesting week. Considering I did not leave my house during that time, that is saying something. I developed mild upper respiratory infection symptoms 10 days ago, tested positive for COVID-19 the next day, and started Paxlovid therapy that evening. I never got terribly ill, and the Paxlovid was a piece of cake. However, I developed hoarseness the following Wednesday, just as I was stopping Paxlovid.
|
|
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
A clinical trial led by Georgetown Lombardi Deputy Director Michael Atkins, MD, showed a remarkable 20% advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy (72% survival rate) versus those who initially got targeted therapies (52% survival rate). Read more about this research.
|
|
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors led by Jeanne Mandelblatt, MD, MPH, and involving several other Georgetown Lombardi members adds important evidence to that potential link. Read more about this study.
|
|
Research Addresses the Potential of a New Way to Help Breast Cancer Survivors Solve Insomnia
|
|
Up to three American Cancer Society Institutional Research Grant (IRG) Pilot Project Grants will be funded to help launch promising new projects by early career faculty members. These are one-year, non-renewable $30,000 research grants that are funded through Georgetown Lombardi’s IRG, which is sponsored by the American Cancer Society. View eligibility criteria, full application, and submission instructions. Application deadline: 11:59 p.m., Monday, November 14.
|
|
Mask-Wearing in Indoor Instructional Settings on Campus Now Optional
As of Wednesday, September 28, wearing a mask is now optional in indoor instructional settings on the Main and Medical Center campuses, such as classrooms and teaching laboratories, in addition to other locations where they are already optional. Read the full guidance.
|
|
Monday, October 3
2:00 - 3:00 p.m.
Presented by Marcia C. Haigis, PhD, professor, Department of Cell Biology and director, Gender Equity for Faculty in Science, Harvard Medical School. Sponsored by the Center for Metabolomic Studies at Georgetown Lombardi. Join this seminar via Zoom.
|
|
Tuesday, October 4
9:00 - 10:00 a.m.
|
|
Tuesday, October 4
12:15 - 1:15 p.m.
|
|
Thursday, October 6
9:00 - 10:00 a.m.
Via Zoom
Nanxi Huang, PhD candidate in the Tumor Biology program, presents “The Role of HAI-2 in the Intestine Depends on its Correct Subcellular Targeting.” Mentor: Michael Johnson, PhD, and Chen-Yong Lin, PhD. Join the meeting in W302 Research Building or via Zoom.
|
|
Is Software Patentable?
Thursday, October 6
10:00 - 11:00 a.m.
Leavey Center, Program Room or via Zoom
Jonathan King, JD, patent prosecution attorney, Blank Rome, LLP, discusses the types of software innovations that are eligible for patenting, the steps that can be taken to increase the likelihood of obtaining patent protection, and the non-patent ways to protect innovative software at this Invention 2 Innovation Seminar presented by the Office of Technology Commercialization. Register for this program.
|
|
Thursday, October 6
3:00 - 4:00 p.m.
Presented by Daniel Drucker, MD, senior scientist, Lunenfeld-Tanenbaum Research Institute, and professor of medicine, University of Toronto. Sponsored by the Office of the Dean for Research. Join this seminar via Zoom.
|
|
Friday, October 7
12:00 - 1:00 p.m.
Presented by Carolyn Y. Fang, PhD, professor and co-leader, Cancer Prevention and Control Program, and associate director for population science, Fox Chase Cancer Center. Join this lecture via Zoom.
|
|
Registration Now Open for Ruesch Symposium
|
|
Funding and Award Opportunities |
|
AACR Clinical Oncology Research (CORE) Training Fellowships Program
|
|
Cancer Immunotherapy Translational Research Program Grant
The Cancer Research Institute offers Clinic and Laboratory Integration Program (CLIP) grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grants support basic, preclinical, and translational research that provides information that can be directly applied to optimizing cancer immunotherapy in the clinic. Proposals in all cancers are encouraged. Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. Funding: $200,000 over two years. LOI deadline: December 1. Full application deadline: March 1, 2023. View application guidelines.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | IO Metastatic NSCLC – Dr. Reuss | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | Protocol Writing Series – Dr. Weinberg | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | BMT Complications – Dr. Ali | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Nanxi Huang: “The Role of HAI-2 in the Intestine Depends on its Correct Subcellular Targeting” | Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Bone Marrow Collection – Dr. Broome | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
